Contrast-Enhanced Endoscopic Ultrasound for Differentially Diagnosing Autoimmune Pancreatitis and Pancreatic Cancer
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: Differentially diagnosing focal-type autoimmune pancreatitis (f-AIP) and pancreatic cancer (PC) is challenging. Contrast-enhanced harmonic endoscopic ultrasound (CEH-EUS) may provide information for differentiating pancreatic masses. In this study, we evaluated the usefulness of CEH-EUS in differentiating f-AIP from PC. Methods: Data were collected prospectively and analyzed on patients who underwent CEH-EUS between May 2014 and May 2015. Eighty consecutive patients were diagnosed with f-AIP or PC. PC and f-AIP were compared for enhancement intensity, contrast agent distribution, and internal vasculature. Results: The study group comprised 53 PC patients and 27 f-AIP patients (17 with type-1 AIP [15 definite and two probable], two with probable type-2 AIP, and eight with AIP, not otherwise specified). Hyper- to iso-enhancement in the arterial phase (f-AIP, 89% vs PC, 13%; p<0.05), homogeneous contrast agent distribution (f-AIP, 81% vs PC, 17%; p<0.05), and absent irregular internal vessels (f-AIP, 85% vs PC, 30%; p<0.05) were observed more frequently in the f-AIP group. The combination of CEH-EUS and enhancement intensity, absent irregular internal vessels improved the specificity (94%) in differentiating f-AIP from PC. Conclusions: CEH-EUS may be a useful noninvasive modality for differentially diagnosing f-AIP and PC. Combined CEH-EUS findings could improve the specificity of CEH-EUS in differentiating f-AIP from PC.
Abstract
Background/Aims: Differentially diagnosing focal-type autoimmune pancreatitis (f-AIP) and pancreatic cancer (PC) is challenging. Contrast-enhanced harmonic endoscopic ultrasound (CEH-EUS) may provide information for differentiating pancreatic masses. In this study, we evaluated the usefulness of CEH-EUS in differentiating f-AIP from PC. Methods: Data were collected prospectively and analyzed on patients who underwent CEH-EUS between May 2014 and May 2015. Eighty consecutive patients were diagnosed with f-AIP or PC. PC and f-AIP were compared for enhancement intensity, contrast agent distribution, and internal vasculature. Results: The study group comprised 53 PC patients and 27 f-AIP patients (17 with type-1 AIP [15 definite and two probable], two with probable type-2 AIP, and eight with AIP, not otherwise specified). Hyper- to iso-enhancement in the arterial phase (f-AIP, 89% vs PC, 13%; p<0.05), homogeneous contrast agent distribution (f-AIP, 81% vs PC, 17%; p<0.05), and absent irregular internal vessels (f-AIP, 85% vs PC, 30%; p<0.05) were observed more frequently in the f-AIP group. The combination of CEH-EUS and enhancement intensity, absent irregular internal vessels improved the specificity (94%) in differentiating f-AIP from PC. Conclusions: CEH-EUS may be a useful noninvasive modality for differentially diagnosing f-AIP and PC. Combined CEH-EUS findings could improve the specificity of CEH-EUS in differentiating f-AIP from PC.
참고문헌 (24)
- Moon SH, "Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study", Gut, 57, pp.1704~1712 (2008)[DOI]
- Chari ST, "Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience", Clin Gastroenterol Hepatol, 4, pp.1010~1016 (2006)[DOI]
- Shimosegawa T, "International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology", Pancreas, 40, pp.352~358 (2011)[DOI]
- Majumder S, "EUS-guided FNA for diagnosing autoimmune pancreatitis: does it enhance existing consensus criteria?", Gastrointest Endosc, 84, pp.805~807 (2016)[DOI]
- Bang JY, "Objective assessment of an algorithmic approach to EUS-guided FNA and interventions", Gastrointest Endosc, 77, pp.739~744 (2013)[DOI]
- Kitano M, "Contrast-enhanced harmonic endoscopic ultrasonography for pancreatobiliary diseases", Dig Endosc, 27(Suppl 1), pp.60~67 (2015)[DOI]
- Hocke M, "Contrast-enhanced endoscopic ultrasound in the diagnosis of autoimmune pancreatitis", Endoscopy, 43, pp.163~165 (2011)[DOI]
- Gong TT, "Contrast-enhanced EUS for differential diagnosis of pancreatic mass lesions: a meta-analysis", Gastrointest Endosc, 76, pp.301~309 (2012)[DOI]
- Saftoiu A, "Contrast-enhanced harmonic endoscopic ultrasound", Endoscopy, 44, pp.612~617 (2012)[DOI]
- Numata K, "Contrast-enhanced sonography of autoimmune pancreatitis: comparison with pathologic findings", J Ultrasound Med, 23, pp.199~206 (2004)[DOI]
- Fusaroli P, "Contrast harmonic echo-endoscopic ultrasound improves accuracy in diagnosis of solid pancreatic masses", Clin Gastroenterol Hepatol, 8, pp.629~634 (2010)[DOI]
- Kitano M, "A novel perfusion imaging technique of the pancreas: contrast-enhanced harmonic EUS (with video)", Gastrointest Endosc, 67, pp.141~150 (2008)[DOI]
- 이태윤, "Clinical Role of Contrast-Enhanced Harmonic Endoscopic Ultrasound in Differentiating Solid Lesions of the Pancreas: A Single-Center Experience in Korea", Gut and Liver, 7(5), pp.599~604 (2013), 거트앤리버 소화기연관학회협의회
- Claudon M, "Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)-update 2008", Ultraschall Med, 29, pp.28~44 (2008)[DOI]
- Hocke M, "Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer", World J Gastroenterol, 12, pp.246~250 (2006)[DOI]
- Chari ST, "A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer", Clin Gastroenterol Hepatol, 7, pp.1097~1103 (2009)[DOI]
- Levy MJ, "Chronic pancreatitis: focal pancreatitis or cancer? Is there a role for FNA", biopsy? Autoimmune pancreatitis, 2006, pp.38(Suppl 1), S30~S35
- Mizuno N, "Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA", J Gastroenterol, 44, pp.742~750 (2009)[DOI]
- Detlefsen S, "Autoimmune pancreatitis", Scand J Gastroenterol, 44, pp.1391~1407 (2009)[DOI]
- Bang SJ, "Is pancreatic core biopsy sufficient to diagnose autoimmune chronic pancreatitis?", Pancreas, 36, pp.84~89 (2008)[DOI]
- Morishima T, "Prospective multicenter study on the usefulness of EUS-guided FNA biopsy for the diagnosis of autoimmune pancreatitis", Gastrointest Endosc, 84, pp.241~248 (2016)[DOI]
- Sanchez MV, "EUS contrast agents: what is available, how do they work, and are they effective?", Gastrointest Endosc, 69(2 Suppl), pp.S71~S77 (2009)[DOI]
- Imazu H, "Novel quantitative perfusion analysis with contrast-enhanced harmonic EUS for differentiation of autoimmune pancreatitis from pancreatic carcinoma", Scand J Gastroenterol, 47, pp.853~860 (2012)[DOI]
- Matsubara H, "Dynamic quantitative evaluation of contrast-enhanced endoscopic ultrasonography in the diagnosis of pancreatic diseases", Pancreas, 40, pp.1073~1079 (2011)[DOI]